Axa’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-448,642
| Closed | -$4.28M | – | 1068 |
|
|
2023
Q2 | $4.28M | Buy |
448,642
+6,163
| +1% | +$58.7K | 0.01% | 589 |
|
|
2023
Q1 | $4.87M | Buy |
442,479
+106,693
| +32% | +$1.17M | 0.02% | 572 |
|
|
2022
Q4 | $4.97M | Sell |
335,786
-1,809
| -0.5% | -$26.8K | 0.02% | 600 |
|
|
2022
Q3 | $6.45M | Buy |
337,595
+113,963
| +51% | +$2.18M | 0.03% | 526 |
|
|
2022
Q2 | $4.77M | Sell |
223,632
-131,311
| -37% | -$2.8M | 0.02% | 591 |
|
|
2022
Q1 | $6.84M | Buy |
354,943
+58,690
| +20% | +$1.13M | 0.02% | 567 |
|
|
2021
Q4 | $6.14M | Buy |
296,253
+37,169
| +14% | +$771K | 0.02% | 613 |
|
|
2021
Q3 | $6.19M | Buy |
259,084
+15,720
| +6% | +$376K | 0.02% | 628 |
|
|
2021
Q2 | $6.64M | Buy |
243,364
+18,816
| +8% | +$513K | 0.02% | 636 |
|
|
2021
Q1 | $6.5M | Buy |
+224,548
| New | +$6.5M | 0.02% | 636 |
|